(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 10.23% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Tilray Brands's revenue in 2026 is $915,454,000.On average, 13 Wall Street analysts forecast TLRY's revenue for 2027 to be $149,687,733,321, with the lowest TLRY revenue forecast at $119,005,153,080, and the highest TLRY revenue forecast at $166,440,773,538. On average, 12 Wall Street analysts forecast TLRY's revenue for 2028 to be $160,720,223,220, with the lowest TLRY revenue forecast at $124,447,848,097, and the highest TLRY revenue forecast at $172,842,341,751.
In 2029, TLRY is forecast to generate $165,078,737,748 in revenue, with the lowest revenue forecast at $147,099,865,320 and the highest revenue forecast at $179,652,520,701.